Insulin Secretory Capacity in Insulin-independent Pancreas-Kidney Recipients Compared to Controls
NCT ID: NCT00618761
Last Updated: 2012-06-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
40 participants
INTERVENTIONAL
2004-10-31
2014-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hyperglycemia and (Pre)Diabetes in Pediatric Renal and Liver Transplantation.
NCT05464043
Kidney Alone Versus Islet-After-Kidney in Type 1 Diabetic Kidney Transplant Recipient.
NCT05662267
Optimal A1c Control in Post Liver or Combined Liver and Kidney Transplant Recipients Who Have Diabetes Mellitus
NCT04216303
Islet Cell Transplantation in Patients With Type I Diabetes With Previous Kidney Transplantation
NCT01123187
Quality of Life in Pancreas Transplantation
NCT03921593
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
kidney-pancreas recipients
hyperglycemic clamp test
hyperglycemic clamp test
2
kidney recipients
hyperglycemic clamp test
hyperglycemic clamp test
3
healthy controls
hyperglycemic clamp test
hyperglycemic clamp test
4
beta-cell recipients
hyperglycemic clamp test
hyperglycemic clamp test
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
hyperglycemic clamp test
hyperglycemic clamp test
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* kidney recipients
* healthy volunteers
* beta-cell recipients
* immunosuppression with MMF-Tacrolimus
* 1-4 years after transplantation
Exclusion Criteria
* insulin dependent
21 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Juvenile Diabetes Research Foundation
OTHER
Fund for Scientific Research, Flanders, Belgium
OTHER
University Hospital, Gasthuisberg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pieter Gillard
Prof Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chantal Mathieu, M.D., PhD
Role: PRINCIPAL_INVESTIGATOR
UZ-Gasthuisberg, Department of Endocrinology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Endocrinology, Leuven, UZ-Gasthuisberg
Leuven, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JDRF 4/2005/1327
Identifier Type: -
Identifier Source: secondary_id
clamp01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.